'Wild West' of Suits Coming for Wellness By Al Lewis There is panic over the sunsetting of the safe harbor for incentives/penalties for health risk assessments and biometric screenings.
Awareness: The Best Insurance Policy By Lewis Fein Insurers should support organizations whose mission is to save lives by teaching life-saving techniques. Be champions of change.
Benefits Advisers: It's About to Get Real By Kevin Trokey However unfair, benefits advisers need to brace themselves for the picture that Bezos/Buffett/Dimon are about to paint of them.
High Time to Trust Patients, Physicians By Marilyn Singleton The days of trusting legislators to have our best interests at heart are in the rearview mirror. It's time for doctors and patients to take the lead.
More Opportunities for Reinsurers in Health By Hugh Carter Donahue Market liberalization initiatives present even more opportunities for innovators in transparent health reinsurance.
Renaissance of the Annuity via Insurtech By Rick Huckstep The conventional annuity looks tired in the digital world. It’s an old world approach long overdue for a refresh and reinvention.
Bridging Health and Productivity at Work By Kimberly George Mark Walls Programs that focus equally on employees' health and productivity are becoming essential for companies.
Where Is the Elon Musk of Healthcare? By Fred Goldstein It is time for healthcare to declare a grand mission like the one aimed at Mars that has driven Elon Musk's radical innovation in rockets.
Auto Insurance in an Existential Crisis By Stephen Applebaum Alan Demers The 125-year-old, $300 billion U.S. auto insurance industry is caught between runaway inflation and strained consumer wallets.
The Promise of Continuous Underwriting By Bill Deemer Bobby Touran Typically, a risk is underwritten, bound... and forgotten. But new streams of data and automation allow for continuous underwriting.
Convergence and the Insurance Ecosystem By Stephen Applebaum Alan Demers Companies must anticipate the future, innovate beyond their core and transform their capabilities as rapidly as technology allows.
Lemonade's 'Synthetic Agent' Nonsense By Matteo Carbone Desperate for growth, Lemonade produces another howler: A lender receiving a 16% interest rate is presented as a (synthetic) agent.